| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.04 | 0.8 |